3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
9
Glioblastoma
9
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
6
Brain Neoplasms
6
Glioma
5
Breast Neoplasms
5
Oligodendroglioma
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Colorectal Neoplasms
4
Astrocytoma
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Neoplasms
3
Meningioma
3
Medulloblastoma
3
Gliosarcoma
3
Glioma, Subependymal
3
Ependymoma
3
Central Nervous System Neoplasms
3
Carcinoma, Renal Cell
3
Sarcoma
2
Platinum-Refractory Fallopian Tube Carcinoma
2
Pinealoma
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Hematologic Neoplasms
2
Interventions
pertuzumab
1
cc-486
1
Trastuzumab
1
Sulindac
1
Magnetic Resonance Spectroscopy
1
Epirubicin
1
Docetaxel
1
Cytarabine
1
Carboplatin
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Pathologic Complete Response
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01956513
2013-10-08
ADC
Centre Jean Perrin
Phase NA
Withdrawn